Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification

OBJECTIVES: To estimate the costs of providing extended-release injectable naltrexone (XR-NTX) and buprenorphine-naloxone (BUP-NX) following inpatient detoxification using data derived from a multisite randomized controlled trial at 8 US community-based treatment programs. STUDY DESIGN: Cost data we...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Manag Care
Autores principales: McCollister, Kathryn E., Leff, Jared A., Yang, Xuan, Lee, Joshua D., Nunes, Edward V., Novo, Patricia, Rotrosen, John, Schackman, Bruce R., Murphy, Sean M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6345513/
https://ncbi.nlm.nih.gov/pubmed/30452209
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares